Literature DB >> 3717186

Beta-lactam/aminoglycoside combinations: interactions and their mechanisms.

R C Moellering, G M Eliopoulos, J D Allan.   

Abstract

Combinations of beta-lactams with aminoglycosides are widely used in the therapy of infections. There are a number of theoretic advantages to using such combinations. Indeed, combinations of beta-lactams and aminoglycosides usually result in synergism or indifference and very rarely in antagonism. The mechanisms of synergism, resistance to synergism, and antagonism have been studied extensively in enterococci; further studies are necessary to define such mechanisms in other organisms.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3717186

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

Review 1.  Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.

Authors:  Mical Paul; Adi Lador; Simona Grozinsky-Glasberg; Leonard Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2014-01-07

Review 2.  Infections in neutropenic patients. II: Management.

Authors:  P Engervall; M Björkholm
Journal:  Med Oncol       Date:  1996-03       Impact factor: 3.064

3.  Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniae.

Authors:  N Desbiolles; L Piroth; C Lequeu; C Neuwirth; H Portier; P Chavanet
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

4.  Pharmacodynamic effects of extended dosing intervals of imipenem alone and in combination with amikacin against Pseudomonas aeruginosa in an in vitro model.

Authors:  B J McGrath; K C Lamp; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

Review 5.  Antibiotic adjuvants: identification and clinical use.

Authors:  Patricia Bernal; Carlos Molina-Santiago; Abdelali Daddaoua; María A Llamas
Journal:  Microb Biotechnol       Date:  2013-02-28       Impact factor: 5.813

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.